
AlphaFold Slashes Drug Discovery Time From Months to Seconds
AlphaFold may reduce the time and cost needed to discover new drug targets, with some protein structures now appearing in seconds instead of months. Case studies suggest that AlphaFold models can speed up drug discovery in about one-third of projects, and target selection may become more effective using large-scale genetic data. Automation and single-cell assays might improve the accuracy and speed of early drug screening. Financial reports and partnerships appear to show growing industry trust in these new AI tools, though experimental checks and regulatory proof are still required. Experts suggest these computational methods could make research and development more efficient, but results can vary by case.













